Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 2, 2016 and accepted by EDGAR at Aug 2, 2016, 16:41 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$43.73bnus-gaap:Revenues
Revenue6 months2016-01-01 to 2016-06-30$86.94bnus-gaap:Revenues
Cost of revenue3 months2016-04-01 to 2016-06-30$36.71bnus-gaap:CostOfRevenue
Cost of revenue6 months2016-01-01 to 2016-06-30$73.18bnus-gaap:CostOfRevenue
Gross profit3 months2016-04-01 to 2016-06-30$7.01bnus-gaap:GrossProfit
Gross profit6 months2016-01-01 to 2016-06-30$13.76bnus-gaap:GrossProfit
Operating income3 months2016-04-01 to 2016-06-30$2.35bnus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30$4.53bnus-gaap:OperatingIncomeLoss
Interest expense3 months2016-04-01 to 2016-06-30$284.0mus-gaap:InterestExpense
Interest expense6 months2016-01-01 to 2016-06-30$572.0mus-gaap:InterestExpense
Income tax3 months2016-04-01 to 2016-06-30$604.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-01-01 to 2016-06-30$1.35bnus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2016-04-01 to 2016-06-30$0.86us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30$1.90us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-04-01 to 2016-06-30$0.86us-gaap:EarningsPerShareBasic
Basic EPS6 months2016-01-01 to 2016-06-30$1.91us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-04-01 to 2016-06-301,075,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2016-01-01 to 2016-06-301,087,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2016-01-01 to 2016-06-30$4.02bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2016-01-01 to 2016-06-30$1.10bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2016-01-01 to 2016-06-30$929.0mus-gaap:PaymentsOfDividends
Share repurchases6 months2016-01-01 to 2016-06-30$3.96bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-06-30$1.13bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$29.45bnus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$92.75bnus-gaap:Assets
Current liabilitiesAt period end2016-06-30$26.57bnus-gaap:LiabilitiesCurrent
Short-term borrowingsAt period end2016-06-30$745.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2016-06-30$34.76bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-16-000090. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.